,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['breast', 'enhertu']
"the results are phenomenally spectacular, ken takeshita, m.d. #asco2022 #enhertu #breastcancer #her2 
My passion is to improve outcomes for healthcare.